Part 12, Reference for Chapter 141: Basal Cell Carcinoma
Skip chapter table of contents and go to main content
Basal cell carcinoma
- 1 Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol 2013;38:367–9.Cross Ref linkPubmed link , , , .
- 2 Population‐based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012;148:347–54.Cross Ref linkPubmed link , , , et al.
- 3 Cancer statistics 1990. CA Cancer J Clin 1990;40:9–26.Cross Ref linkPubmed link , , .
- 4 Epidemiology and economic burden of nonmelanoma skin cancer. Facial Plast Surg Clin North Am 2012;20:419–22.Cross Ref linkPubmed link , , .
- 5 Variations in registration of skin cancer in the United Kingdom. Clin Exp Dermatol 2004;29:328–30.Cross Ref linkPubmed link , , .
- 6 Cancer Research UK. http://www.cancerresearchuk.org/cancer‐info/cancerstats/types/skin/incidence/uk‐skin‐cancer‐incidence‐statistics#nmsc (last accessed April 2015).
- 7 National Cancer Intelligence Network (NCIN). Non‐melanoma Skin Cancer in England, Scotland, Northern Ireland, and Ireland. London: NCIN, 2013.
- 8 National Cancer Intelligence Network (NCIN) Data Briefing. The Importance of Skin Cancer Registration. London: NCIN, 2010.
- 9 Trends in Basal cell carcinoma incidence rates: a 37‐year Dutch observational study. J Invest Dermatol 2013;133:913–18.Cross Ref linkPubmed link , , , , , .
- 10 Non‐melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol 2014;134:43–50.Cross Ref linkPubmed link , , , et al.
- 11 A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069–80.Cross Ref linkPubmed link , , .
- 12 Skin cancer incidence and the ageing population. Br J Dermatol 2005;153:679–80.Cross Ref linkPubmed link , .
- 13 Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874–81.Cross Ref linkPubmed link , , , et al.
- 14 A meta‐analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol 2013;37:534–43.Cross Ref linkPubmed link , , , et al.
- 15 Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta‐analysis. Eur J Cancer 2013;49:2365–75.Cross Ref linkPubmed link , , , , .
- 16 The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 1999;135:843–4.Pubmed link .
- 17 Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta‐analysis of the epidemiological literature. Br J Dermatol 2011;165:612–25.Pubmed link , , .
- 18 A dose–response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482–8.Cross Ref linkPubmed link , , , .
- 19 Does intermittent sun exposure cause basal cell carcinoma? A case–control study in Western Australia. Int J Cancer 1995;60:489–94.Cross Ref linkPubmed link , , , .
- 20 The multicentre south European study ‘Helios’ II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996;73:1447–54.Cross Ref linkPubmed link , , , et al.
- 21 Non‐melanoma skin cancer. Lancet 2010;375:673–85.Cross Ref linkPubmed link , , .
- 22 How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses. J Invest Dermatol 2007;127:2103–5.Cross Ref linkPubmed link .
- 23 Cellular and sub‐cellular responses to UVA in relation to carcinogenesis. Int J Radiat Biol 2009;85:177–95.Cross Ref linkPubmed link , , , .
- 24 Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 2000;142:8–15.Cross Ref linkPubmed link , , , .
- 25 Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes. Clin Exp Dermatol 2005;30:49–55.Cross Ref linkPubmed link , , , .
- 26 Mutational landscape of basal cell carcinomas by whole‐exome sequencing. J Invest Dermatol 2014;134:213–20.Cross Ref linkPubmed link , , , .
- 27 The tumour‐suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996;384:129–34.Cross Ref linkPubmed link , , , et al.
- 28 GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas. Nature 2013;494:484–8.Cross Ref linkPubmed link , , , , .
- 29 PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer 2006;95:548–53.Cross Ref linkPubmed link , , , et al.
- 30 Systemic treatments for basal cell carcinoma (BCC): the advent of dermato‐oncology in BCC. Br J Dermatol 2013;169:53–7.Cross Ref linkPubmed link , .
- 31 ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008;40:886–91.Cross Ref linkPubmed link , , , et al.
- 32 Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 2006;154 Suppl. 1:8–10.Cross Ref linkPubmed link .
- 33 Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 2000;142:8–15.Cross Ref linkPubmed link , , , .
- 34 Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S‐transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev 1999;8:61–7.Pubmed link , , , et al.
- 35 Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia. Hum Pathol 2007;38:1023–9.Cross Ref linkPubmed link , , , et al.
- 36 Increased immunoreactivity of membrane type‐1 matrix metalloproteinase (MT1‐MMP) and β‐catenin in high‐risk basal cell carcinoma. Br J Dermatol 2011;165:1197–204.Cross Ref linkPubmed link , , , , , .
- 37 The role of immunosuppression in the pathogenesis of basal cell carcinoma. Br J Dermatol 2006;154:790–1.Cross Ref linkPubmed link , , , et al.
- 38 A population‐based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154:498–504.Cross Ref linkPubmed link , , , , , .
- 39 Roles of the immune system in skin cancer. Br J Dermatol 2011;165:953–65.Cross Ref linkPubmed link , .
- 40 High recurrence rates of Basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004;140:985–8.Pubmed link , , , et al.
- 41 Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case–control study. Environ Health Perspect 2012;120:721–6.Cross Ref linkPubmed link , , , et al.
- 42 The photocarcinogenic risk of narrowband UVB (TL‐01) phototherapy: early follow‐up data. Br J Dermatol 2005;152:755–7.Cross Ref linkPubmed link , , , , .
- 43 Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000;136:1007–11. , , , et al.
- 44 Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol 2012;22:299–309.Pubmed link , , , .
- 45 The modulating influence of stromal environment on epithelial cells studied in human autotransplants. J Invest Dermatol 1961;36:109–17.Cross Ref linkPubmed link , .
- 46 Cell proliferation in human basal cell carcinoma. Cancer Res 1970;30:724–8.Pubmed link , .
- 47 Amyloid in basal cell carcinomas. Br J Dermatol 1979;101:141–6.Cross Ref linkPubmed link , .
- 48 Studies on basal‐cell epithelioma of the skin: the architecture, manner of growth, and histogenesis of the tumours – whole tumours examined in serial sections cut parallel to the skin surface. Acta Pathol Microbiol Scand Suppl 1965;117:3–63. .
- 49 The architecture of basal‐cell carcinoma. Br J Dermatol 1961;73:455–74.Cross Ref linkPubmed link .
- 50 Correlation of basal cell epithelioma aggressiveness with local inhibition of host lymphocyte response. Clin Res 1982;30:266 (Abstract). , , .
- 51 Immunolabeling pattern of podoplanin (d2‐40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases. Am J Dermatopathol 2010;32:683–7.Cross Ref linkPubmed link , , , , .
- 52 Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples. Mod Pathol 2012;25:1345–53.Cross Ref linkPubmed link , , .
- 53 Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006;19 Suppl. 2:S127–47.Cross Ref linkPubmed link .
- 54 Metastatic basal cell carcinoma: a clinicopathologic study of 17 cases. Cancer 1980;46:748–57.Cross Ref linkPubmed link , .
- 55 Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes. Arch Dermatol 1997;133:593–6.Cross Ref linkPubmed link , , .
- 56 Cutaneous basal cell carcinomas. Cancer 2001;92:354–8.Cross Ref linkPubmed link , , , et al.
- 57 Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118–26.Cross Ref linkPubmed link , , .
- 58 Why classify basal cell carcinomas? Histopathology 1998;32:393–8.Cross Ref linkPubmed link .
- 59 Invasive basal cell carcinoma of the head and neck (basalioma terebrans). Facial Plastic Surg 2011;27:258–65.Cross Ref link .
- 60 Aggressive basal cell carcinoma of the scalp. Arch Dermatol 1978;114:782–3.Cross Ref linkPubmed link , .
- 61 Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 2005;9:10–15.Cross Ref linkPubmed link , , .
- 62 Metastatic basal cell carcinoma of the lung. South Med J 1980;73:647–9.Cross Ref linkPubmed link , , .
- 63 Clinical diagnostic accuracy of basal cell carcinoma. J Am Acad Dermatol 1987;16:988–90.Cross Ref linkPubmed link , .
- 64 Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 2013;27:894–8.Cross Ref linkPubmed link , , , et al.
- 65 Update on non‐melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring. Exp Rev Anticancer Ther 2013;13:541–58.Cross Ref link , , , et al.
- 66 Noninvasive diagnostic tools for nonmelanoma skin cancer. Br J Dermatol 2007;157 S2:56–8.Cross Ref linkPubmed link , , , .
- 67 Imaging of basal cell carcinoma by high‐definition optical coherence tomography: histomorphological correlation. A pilot study. Br J Dermatol 2012;167:856–64.Cross Ref linkPubmed link , , , .
- 68 Validation of fluorescent confocal microscopy criteria and histopathological correlation for the diagnosis of basal cell carcinoma and most common subtypes. Br J Dermatol 2014;170:360–5.Cross Ref linkPubmed link , , , .
- 69 British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35–48.Cross Ref linkPubmed link , , ;
- 70 Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007;24;CD003412. , , , .
- 71 Interventions for preventing non‐melanoma skin cancers in high‐risk groups. Cochrane Database Syst Rev 2007;4:CD005414.Pubmed link , , , , , .
- 72 Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol 2003;149 Suppl. 66:57–8.Cross Ref linkPubmed link , , , et al.
- 73 Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatol Surg 2013;39:1306–16.Cross Ref linkPubmed link , , .
- 74 A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low‐risk nodular basal cell carcinoma. J Am Acad Dermatol 2007;57:616–21.Cross Ref linkPubmed link , , , et al.
- 75 Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness‐based definition of sBCC. Br J Dermatol 2013;169:549–54.Cross Ref linkPubmed link , , , et al.
- 76 Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal‐cell carcinoma: a single blind, non‐inferiority, randomised controlled trial. Lancet Oncol 2013;14:647–54.Cross Ref linkPubmed link , , , et al.
- 77 The effect of 5‐fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5‐FU. Arch Dermatol Res 1990;282:484–6.Cross Ref linkPubmed link , , .
- 78 5% 5‐Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433–9.Pubmed link , , .
- 79 Long‐term follow‐up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy. J Am Acad Dermatol 2006;54:1033–8.Cross Ref linkPubmed link , , , .
- 80 Oral hedgehog pathway inhibitors for basal cell carcinoma. N Engl J Med 2012;366:2225–6.Cross Ref linkPubmed link .
- 81 Efficacy and safety of vismodegib in advanced basal‐cell carcinoma. N Engl J Med 2012;366:2171–9.Cross Ref linkPubmed link , , , et al.
- 82 Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient. Dermatol Surg 2012;38:1863–6.Cross Ref linkPubmed link , , , et al.
- 83 Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340–4.Cross Ref linkPubmed link , .
- 84 Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 2006;47:1–12.Cross Ref linkPubmed link , .
- 85 Long‐term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow‐up. J Dermatol Surg Oncol 1989;15:315–28.Cross Ref linkPubmed link , , , et al.
- 86 Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatol Surg 2013;39:719–25.Cross Ref linkPubmed link , , .
- 87 Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000;26:759–64.Cross Ref linkPubmed link , , , , .
- 88 Long‐term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:1169–73.Cross Ref linkPubmed link , , , et al.
- 89 Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re‐treated carcinomas in 229 patients. Eur J Dermatol 2001;11:25–8.Pubmed link , , .
- 90 The important role of radiotherapy in patients with non‐melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol 2008;52:278–86.Cross Ref linkPubmed link .
- 91 Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100–6.Cross Ref linkPubmed link , , , et al.
- 92 Radiation‐sensitive genetically susceptible pediatric sub‐populations. Pediatr Radiol 2009;39:S27–31.Cross Ref linkPubmed link .
- 93 Late irradiation damage to the skin caused by soft X‐ray radiation therapy of cutaneous tumors. Arch Dermatol 1995;131:182–6.Cross Ref linkPubmed link , , .
- 94 Superpulsed CO2 laser treatment of basal cell carcinoma with intraoperatory histopathologic and cytologic examination. Dermatol Surg 2002;28:909–11.Pubmed link , , , et al.
- 95 Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high‐energy pulsed carbon dioxide laser. Arch Dermatol 1998;134:1247–52.Pubmed link , , , et al.
- 96 Recurrent basal cell carcinoma following ablative laser procedures. J Am Acad Dermatol 2011;64:723–9.Cross Ref linkPubmed link , , , et al.
- 97 The pulsed dye laser for the treatment of basal cell carcinoma. Lasers Med Sci 2011;26:641–4.Cross Ref linkPubmed link , , , et al.
- 98 Detection of BCCs in Mohs excisions with fluorescence confocal mosaicing microscopy. Br J Dermatol 2009;160:1242–50.Cross Ref linkPubmed link , , , et al.
Fibroepithelial basal cell carcinoma
- 99 Fibroepithelioma of Pinkus is a fenestrated trichoblastoma. Am J Dermatopathol 2005;27:149–54.Cross Ref linkPubmed link , .
- 100 Fibroepithelioma of Pinkus is a true basal cell carcinoma developing in association with a newly identified tumour‐specific type of epidermal hyperplasia. Br J Dermatol 2012;166:88–97.Cross Ref linkPubmed link , , .
- 101 Dermoscopy patterns of fibroepithelioma of pinkus. Arch Dermatol 2006;142:1318–22.Pubmed link , , , et al.
Naevoid basal cell carcinoma syndrome
- 102 Complications of the naevoid basal cell carcinoma syndrome: results of a population‐based study. J Med Genet 1993;30:460–4.Cross Ref linkPubmed link , , , et al.
- 103 Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008;3:32.Pubmed link .
- 104 Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet A 2010;152:327–32.Cross Ref link , , , et al.
- 105 Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995;13(1):113–25.Pubmed link .
- 106 Pursuit of the pits in the naevoid basal cell carcinoma syndrome. Arch Dermatol 1970;102:586–97.Cross Ref linkPubmed link , .
- 107 Multiple palmar basal cell epitheliomas in basal cell naevus syndrome. Arch Dermatol 1970;10:679–82.Cross Ref link , , .
- 108 Structure and significance of the pits and their tumours in the naevoid basal cell carcinoma syndrome. J Am Acad Dermatol 1980;2:224–38.Cross Ref linkPubmed link , .
- 109 Pathology of the naevoid basal cell carcinoma syndrome. Arch Pathol 1965;79:401–8.Pubmed link , , .
- 110 Molecular genetics of human non‐melanoma skin cancer. Cancer Surv 1996;26:89–114.Pubmed link .
- 111 Human homolog of patched, a candidate gene for the basal cell naevus syndrome. Science 1996;272:1668–71.Cross Ref linkPubmed link , , , et al.
- 112 The Gorlin syndrome gene: a tumor suppressor active in basal cell carcinogenesis and embryonic development. Proc Assoc Am Phys 1995;107:253–7.Pubmed link , , .
- 113 PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer 2006;95:548–53.Cross Ref linkPubmed link , , , et al.
- 114 A girl with deletion 9q22.1‐q22.32 including the PTCH and ROR2 genes identified by genome‐wide array‐CGH. Am J Med Genet A 2007;143:1885–9.Cross Ref link , , , et al.
- 115 Interstitial deletion of chromosome 9, int del(9)(9q22.31‐q31.2), including the genes causing multiple basal cell nevus syndrome and Robinow/brachydactyly 1 syndrome. Eur J Pediatr 2003;162:100–3.Pubmed link , , , et al.
- 116 Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299–308.Cross Ref linkPubmed link , , , et al.
- 117 The basal cell naevus syndrome: disasters occurring among a series of 36 patients. Cancer 1979;44:2294–305.Cross Ref linkPubmed link , .
- 118 Patched mutations and hairy skin patches: a new sign in Gorlin syndrome. Am J Med Genet A 2006;140:2625–30.Cross Ref linkPubmed link , , , et al.
- 119 The naevoid basal cell carcinoma syndrome. Medicine 1987;66:98–113.Cross Ref linkPubmed link .
- 120 Epithelioma adenoides cysticum: basal cell naevi, agenesis of the corpus callosum and dental cysts. Arch Dermatol 1951;63:73–84. , .
- 121 The naevoid basal cell carcinoma syndrome. Am J Hum Genet 1967;19:12–22.Pubmed link , , , et al.
- 122 Basal cell naevus syndrome: combined clinical staff conference at the National Institute of Health. Ann Intern Med 1966;64:403–21.Cross Ref linkPubmed link , , , et al.
- 123 Basal cell naevus syndrome. Arch Dermatol 1964;90:38–53.Cross Ref linkPubmed link , , .
- 124 Multiple naevoid basal‐cell epithelioma, jaw cysts and bifid rib: a syndrome. N Engl J Med 1960;262:908–12.Cross Ref linkPubmed link , .
- 125 Multiple naevoid basal cell carcinoma, odontogenic keratocysts and skeletal anomalies: a syndrome. Acta Derm Venereol (Stockh) 1963;43:39–55. , , .
- 126 The basal‐cell naevus: its relationship to multiple cutaneous cancers and associated anomalies of development. AMA Arch Dermatol 1959;79:67–80.Cross Ref link , .
- 127 Basal cell naevus syndrome. Dermatologica 1967;134:101–6.Cross Ref link , .
- 128 The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991;64:959–61.Cross Ref linkPubmed link , , , et al.
- 129 Complex care by multiple medical and dental specialists of a patient with aggressive Gorlin–Goltz syndrome. Postgrad Med J 2008;84:330–2.Cross Ref linkPubmed link , , , et al.
- 130 Topical chemotherapy with 5‐fluorouracil: a review. J Am Acad Dermatol 1981;4:633–49.Cross Ref linkPubmed link .
- 131 Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell naevus syndrome: a preliminary report. J Dermatol Treat 2002;13:123–7.Cross Ref link , , , et al.
- 132 Management of basal cell carcinoma: which option is best? Postgrad Med 1989;85:57–8,61–3. , .
- 133 Aromatic retinoid in the chemoprevention of the progression of naevoid basal‐cell carcinoma syndrome. J Dermatol Surg Oncol 1984;10:778–81.Cross Ref linkPubmed link , , , .
- 134 Inhibiting the Hedgehog pathway in patients with the basal‐cell nevus syndrome. N Engl J Med 2012;366:2180–218.Cross Ref linkPubmed link , , , et al.
- 135 Oral Hedgehog‐pathway inhibitors for basal‐cell carcinoma. N Engl J Med 2012;366:2225–6.Cross Ref linkPubmed link .
- 136 Gorlin–Goltz syndrome – a medical condition requiring a multidisciplinary approach. Med Sci Monit 2012;18:RA145–53.Cross Ref linkPubmed link , .
Bazex–Dupré–Christol syndrome
- 137 The gene for Bazex–Dupré–Christol syndrome maps to chromosome Xq. J Invest Dermatol 1995;105:87–91.Cross Ref linkPubmed link , , , et al.
- 138 Linkage refinement of Bazex–Dupré–Christol syndrome to an 11·4‐Mb interval on chromosome Xq25‐27.1. Br J Dermatol 2011;165:201–3.Cross Ref linkPubmed link , , , et al.
- 139 Atrophodermie folliculaire proliférations baso‐cellulaires et hypotrichose. Ann Dermatol Syphiligr 1966;93:241–54. , , .
- 140 Multiple familial and pigmented basal cell carcinomas in early childhood – Bazex–Dupré–Christol syndrome. J Eur Acad Dermatol Venereol 2012;26:117–21.Cross Ref linkPubmed link , , .
- 141 The gene for Bazex–Dupré–Christol syndrome maps to chromosome Xq. J Invest Dermatol 1995;105:87–91.Cross Ref linkPubmed link , , , et al.